| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200K | +52.7% | -44.0% |
| R&D Expense | $7.5M | +0.3% | -8.4% |
| SG&A Expense | $7.1M | -5.5% | +0.6% |
| Operating Income | -$14.3M | +3.1% | +3.2% |
| Interest Expense | $2.6M | +44.4% | +23.8% |
| Net Income | -$26.8M | -74.5% | -38.5% |
| EPS (Basic) | -$0.02 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | +5.7% | +55.2% |
| Current Assets | $7.2M | +16.9% | +38.6% |
| Total Assets | $30.6M | +3.6% | +4.4% |
| Current Liabilities | $87.9M | +4.7% | +47.6% |
| Long-term Debt | $72.2M | +11.5% | +35.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.0M | — | — |
| Capital Expenditures | $599K | — | — |
| Investing Cash Flow | -$910K | — | — |
| Financing Cash Flow | $35.7M | — | — |
| Free Cash Flow | -$30.6M | — | — |
| -100.0% |
| +0.0% |
| EPS (Diluted) | -$0.02 | -100.0% | +0.0% |
| $125.9M |
| +8.3% |
| +34.5% |
| Stockholders' Equity | -$108.6M | -8.2% | -35.6% |